Randomized trial demonstrates progression-free survival variation by tumor mutational burden in ovarian cancer, highlighting the value of genomic stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Landen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: